(Q41097702)

English

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

scientific article published on August 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

A Jungwirth

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

G Galvan

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

J Pinski

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

G Halmos

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

K Szepeshazi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

R Z Cai

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

K Groot

7

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

164-172

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Prostate cancer: screening, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970801%2932%3A3%3C164%3A%3AAID-PROS2%3E3.0.CO%3B2-L

21 January 2018

Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer

0 references

The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary

0 references

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

0 references

Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors

0 references

Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice

0 references

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro

0 references

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

0 references

Identification of bone marrow micrometastases in patients with prostate cancer

0 references

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

0 references

Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP

0 references

The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

0 references

Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.

0 references

Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer

0 references

Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer

0 references

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer

0 references

Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095

0 references

Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

0 references

Administration of an LHRH-antagonist to male mice: effects on in vivo secretion of hormones and on the growth of a transplantable human prostatic carcinoma

0 references

Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.

0 references

Inhibitory effects of the new bombesin receptor antagonist RC-3095 on the luteinizing hormone release in rats

0 references

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

0 references

Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination

0 references

Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate

0 references

Synergistic effects of bombesin and epidermal growth factor on cancers

0 references

Inhibition of the pituitary-gonadal axis in nude male mice by continuous administration of LHRH agonists and antagonists

0 references

Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice

0 references

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

0 references

Bombesin stimulates growth of human prostatic cancer cells in vitro

0 references

Interactions between epidermal growth factor-mediated autocrine regulation and linoleic acid-stimulated growth of a human prostate cancer cell line

0 references

Improved silver technique for showing nucleolar organiser regions in paraffin wax sections

0 references

Identifiers

10.1002/(SICI)1097-0045(19970801)32:3<164::AID-PROS2>3.0.CO;2-L

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41097702&oldid=2093467505"